Bruker Corporation
BRKR
$44.96
-$0.60-1.32%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.37B | 3.24B | 3.12B | 3.00B | 2.96B |
| Total Other Revenue | -- | 13.10M | 13.10M | 13.10M | 15.80M |
| Total Revenue | 3.37B | 3.24B | 3.12B | 3.00B | 2.96B |
| Cost of Revenue | 1.68B | 1.62B | 1.54B | 1.48B | 1.45B |
| Gross Profit | 1.68B | 1.62B | 1.58B | 1.52B | 1.52B |
| SG&A Expenses | 892.00M | 854.80M | 803.10M | 759.50M | 727.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 4.30M | 19.80M | 10.90M | 9.30M | 8.10M |
| Total Operating Expenses | 2.96B | 2.85B | 2.69B | 2.56B | 2.48B |
| Operating Income | 410.30M | 388.70M | 433.20M | 442.40M | 489.10M |
| Income Before Tax | 205.20M | 392.30M | 456.70M | 510.70M | 546.20M |
| Income Tax Expenses | 91.40M | 87.80M | 103.80M | 107.60M | 117.70M |
| Earnings from Continuing Operations | 113.80 | 304.50 | 352.90 | 403.10 | 428.50 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -700.00K | 400.00K | -800.00K | -1.50M | -1.30M |
| Net Income | 113.10M | 304.90M | 352.10M | 401.60M | 427.20M |
| EBIT | 410.30M | 388.70M | 433.20M | 442.40M | 489.10M |
| EBITDA | 594.10M | 556.90M | 577.00M | 566.90M | 604.00M |
| EPS Basic | 0.76 | 2.08 | 2.42 | 2.75 | 2.92 |
| Normalized Basic EPS | 1.64 | 1.57 | 1.78 | 1.82 | 1.95 |
| EPS Diluted | 0.76 | 2.08 | 2.41 | 2.75 | 2.92 |
| Normalized Diluted EPS | 1.64 | 1.57 | 1.77 | 1.81 | 1.94 |
| Average Basic Shares Outstanding | 595.70M | 589.60M | 584.70M | 584.10M | 585.70M |
| Average Diluted Shares Outstanding | 597.90M | 591.90M | 587.20M | 586.90M | 588.60M |
| Dividend Per Share | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 |
| Payout Ratio | 26.70% | 9.81% | 8.44% | 7.30% | 6.88% |
